⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6220625 | 0.79 | — | — | |
| SCHEMBL27424068 | 0.77 | — | — | |
| SCHEMBL11301048 | 0.73 | — | — | |
| SCHEMBL31298789 | 0.69 | — | — | |
| SCHEMBL9085758 | 0.69 | — | — | |
| SCHEMBL27901754 | 0.69 | — | — | |
| SCHEMBL11837036 | 0.67 | — | — | |
| SCHEMBL2459512 | 0.64 | — | — | |
| SCHEMBL17593425 | 0.63 | — | — | |
| SCHEMBL28628313 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0787122-A2 | CALCIUM RECEPTOR-ACTIVE COMPOUNDS | NPS PHARMACEUTICALS, INC. (US) | 1997-08-06 | — | — | EP | disclosed |
| WO-1996012697-A2 | CALCIUM RECEPTOR-ACTIVE COMPOUNDS | NPS PHARMACEUTICALS, INC. (US) | 1996-05-02 | — | — | WO | disclosed |